Stock Earnings

Question 1

How did NGENF's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for NervGen Pharma Corp is $-0.13, beating expectations of $-0.05.

Question 2

How did NervGen Pharma Corp NGENF's revenue perform in the last quarter?

Accepted Answer

NervGen Pharma Corp revenue for the last quarter is $-0.13

Question 3

What is the revenue estimate for NervGen Pharma Corp?

Accepted Answer

According to 2 of Wall street analyst, the revenue estimate of NervGen Pharma Corp range from $0.0 to $0.0

Question 4

What's the earning quality score for NervGen Pharma Corp?

Accepted Answer

NervGen Pharma Corp has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does NervGen Pharma Corp report earnings?

Accepted Answer

NervGen Pharma Corp next earnings report is expected in 2025-11-24

Question 6

What are NervGen Pharma Corp's expected earnings?

Accepted Answer

NervGen Pharma Corp expected earnings is $0.0, according to wall-street analysts.

Question 7

Did NervGen Pharma Corp beat earnings expectations?

Accepted Answer

NervGen Pharma Corp recent earnings of $0.0 does not beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '25	$-0.05	$-0.13	+160.0%	BEAT
Q1 '25	$-0.09	$-0.06	-33.33%	MISSED
Q3 '22	$-0.14	$-0.08	-42.85%	MISSED
Q2 '22	$-0.11	$-0.13	+18.18%	BEAT

NervGen Pharma Corp (NGENF) Price

NGENF Stock Price Chart

Latest Earnings Results: Q2 '25

Historical Earnings

Earnings FAQ